ROCHE HOLDINGS AG (RHHBF) Financials
RHHBF Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 107.6 billion | 68.0 billion |
2023-06-30 | 93.8 billion | 60.1 billion |
2023-03-31 | ? | ? |
2022-12-31 | 95.3 billion | 60.7 billion |
RHHBF Free Cash Flow and Stock based compensation
No data available :(
RHHBF Net Income
Date | Net Income |
---|---|
2023-12-31 | 2.6 billion |
2023-06-30 | 4.0 billion |
2023-03-31 | 3.9 billion |
2022-12-31 | 2.1 billion |
RHHBF Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | 1.9 billion |
2023-06-30 | - | - | - |
2023-03-31 | - | - | - |
2022-12-31 | - | - | 1.3 billion |
RHHBF Shares Outstanding
RHHBF Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-06-30 | 967.7 million | - | - | - |
2023-03-31 | 951.8 million | - | - | - |
2022-12-31 | 954.0 million | - | - | - |
RHHBF Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-06-30 | - | - |
2023-03-31 | - | - |
2022-12-31 | - | - |
RHHBF
Price: $280
Dividend Yield: 0.04%
Forward Dividend Yield: 3.90%
Payout Ratio: 69.77%
Dividend Per Share: 10.93 USD
Earnings Per Share: 15.75 USD
P/E Ratio: 16.88
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 197.6 billion
Average Dividend Frequency: 1
Years Paying Dividends: 12
DGR3: 2.97%
DGR5: 2.87%
DGR10: 1.53%